Gast ::
| Hauptseite > Publikationsdatenbank > Volumetry of [11C]-methionine PET uptake as a prognostic marker before treatment of patients with malignant glioma > print |
| Hauptseite > Publikationsdatenbank > Volumetry of [11C]-methionine PET uptake as a prognostic marker before treatment of patients with malignant glioma > print |
| 001 | 201934 | ||
| 005 | 20210129215946.0 | ||
| 037 | _ | _ | |a FZJ-2015-04224 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Dunkl, Veronika |0 P:(DE-Juel1)156211 |b 0 |e Corresponding Author |
| 111 | 2 | _ | |a 16th Congress of the European-Federation-of-Neurological-Societies (EFNS) |c Stockholm |d 2012-09-08 - 2012-09-11 |w Schweden |
| 245 | _ | _ | |a Volumetry of [11C]-methionine PET uptake as a prognostic marker before treatment of patients with malignant glioma |
| 260 | _ | _ | |a Oxford [u.a.]S |c 2012 |b Wiley-Blackwell |
| 300 | _ | _ | |a 63 |
| 336 | 7 | _ | |a Contribution to a conference proceedings |b contrib |m contrib |0 PUB:(DE-HGF)8 |s 1435298120_21656 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |m journal |
| 336 | 7 | _ | |a Conference Paper |0 33 |2 EndNote |
| 336 | 7 | _ | |a CONFERENCE_PAPER |2 ORCID |
| 336 | 7 | _ | |a Output Types/Conference Paper |2 DataCite |
| 336 | 7 | _ | |a conferenceObject |2 DRIVER |
| 336 | 7 | _ | |a INPROCEEDINGS |2 BibTeX |
| 536 | _ | _ | |a 333 - Pathophysiological Mechanisms of Neurological and Psychiatric Diseases (POF2-333) |0 G:(DE-HGF)POF2-333 |c POF2-333 |f POF II |x 0 |
| 700 | 1 | _ | |a Galldiks, Norbert |0 P:(DE-Juel1)143792 |b 1 |u fzj |
| 700 | 1 | _ | |a Kracht, L. |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Vollmar, S. |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Jacobs, A. H. |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Fink, Gereon Rudolf |0 P:(DE-Juel1)131720 |b 5 |u fzj |
| 700 | 1 | _ | |a Schroeter, M. |0 P:(DE-HGF)0 |b 6 |
| 773 | _ | _ | |0 PERI:(DE-600)2020241-6 |p 63 |t European journal of neurology |v 19 |y 2012 |x 1351-5101 |
| 909 | C | O | |o oai:juser.fz-juelich.de:201934 |p VDB |
| 910 | 1 | _ | |a Forschungszentrum Jülich GmbH |0 I:(DE-588b)5008462-8 |k FZJ |b 0 |6 P:(DE-Juel1)156211 |
| 910 | 1 | _ | |a Forschungszentrum Jülich GmbH |0 I:(DE-588b)5008462-8 |k FZJ |b 1 |6 P:(DE-Juel1)143792 |
| 910 | 1 | _ | |a Forschungszentrum Jülich GmbH |0 I:(DE-588b)5008462-8 |k FZJ |b 5 |6 P:(DE-Juel1)131720 |
| 913 | 2 | _ | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-572 |2 G:(DE-HGF)POF3-500 |v (Dys-)function and Plasticity |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Funktion und Dysfunktion des Nervensystems |1 G:(DE-HGF)POF2-330 |0 G:(DE-HGF)POF2-333 |2 G:(DE-HGF)POF2-300 |v Pathophysiological Mechanisms of Neurological and Psychiatric Diseases |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF2 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-3-20090406 |k INM-3 |l Kognitive Neurowissenschaften |x 0 |
| 980 | _ | _ | |a contrib |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a I:(DE-Juel1)INM-3-20090406 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|